Form 4: Nkarta, Inc. Director Simeon George Acquires Stock Options

Director Simeon George acquired 22,500 stock options in Nkarta, Inc. on June 13, 2024.

Summary

• On June 13, 2024, Simeon George, a director of Nkarta, Inc., acquired 22,500 stock options.
• The exercise price of these options is $6.23.
• The options vest 100% on the earlier of June 13, 2025, or the day before the first annual meeting of the Issuer's stockholders after the grant date.
• The options will fully vest upon a change in control of the Issuer or upon the Reporting Person's separation from service due to death or disability.
• The options expire on June 12, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director suggests confidence in the company's future prospects, but it's a routine transaction.

Industry Context

This filing reflects standard executive compensation practices within publicly traded companies, particularly in the biotechnology sector, where stock options are commonly used to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a common component of executive compensation packages in the biotechnology industry.
• Companies like Juno Therapeutics (acquired by Celgene) and Kite Pharma (acquired by Gilead) also utilized stock options extensively to incentivize their executives.
• The vesting schedule and terms described in the document are fairly standard, aligning with typical practices observed in similar companies.

Stakeholder Impact

• The granting of stock options aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates